|
 |
Levonorgestrel Ethinyl EstradiolThis page contains recent news articles, when available, and an overview of Levonorgestrel Ethinyl Estradiol but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.By Amanda Strong. MONTREAL, QC -- October 19, 2005 -- A daily continuous regimen of levonorgestrel plus ethinyl estradiol (LNG/EE) over a 12-month period ... DG News … FDA tentatively OKs generic levonorgestrel/ethinyl estradiol tabs... - Jun 7, 2006 Levonorgestrel ethinyl estradiol tablets USP is the generic equivalent to Duramed Pharmaceuticals' Seasonale tablets, which is indicated for prevention of ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones Levonorgestrel/ethinyl estradiol tablets USP.(NEW GENERICS)(Brief … - Jul 10, 2006 FDA approval has been given to Watson Pharmaceuticals, Corona, Calif., (951) 493-5300, for a generic version of Berlex' oral contraceptive Levlite. $4.95 - Drug Topics - ECNext … FDA tentatively OKs generic levonorgestrel/ethinyl estradiol tabs... - Jun 5, 2006 Levonorgestrel ethinyl estradiol tablets USP is the generic equivalent to Duramed Pharmaceuticals' Seasonale tablets, which is indicated for prevention of ... Pay-Per-View - Women's Health Weekly - Factiva, from Dow Jones Levonorgestrel/ethinyl estradiol tablets USP. - Jul 10, 2006 Levonorgestrel/ethinyl estradiol tablets USP. FDA approval has been given to Watson Pharmaceuticals, Corona, Calif., (951) 493-5300, for a generic version ... $9.94 - Drug Topics - Alacra Store FDA Approves Lybrel for Continuous Contraception - May 31, 2007 May 31, 2007 — The US Food and Drug Administration (FDA) approved a 28-day pill pack of levonorgestrel/ethinyl estradiol 90-µg/20-µg combination tablets ... Medscape … FDA tentatively OKs generic levonorgestrel/ethinyl estradiol tabs... - Jun 9, 2006 Levonorgestrel ethinyl estradiol tablets USP is the generic equivalent to Duramed Pharmaceuticals' Seasonale tablets, which is indicated for prevention of ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Press Release: First Scientific Data for Lybrel(TM) Presented at ASRM... - Oct 17, 2005 First Scientific Data for Lybrel(TM) Presented at ASRM Meeting. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Watson Files Application for Generic SEASONIQUE(R). - ... - Mar 4, 2008 Watson Files Application for Generic SEASONIQUE(R). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Contraception; First scientific data for Lybrel presented at ASRM... - Nov 15, 2005 2005 NOV 15 - (NewsRx.com) -- Wyeth Pharmaceuticals, a division of Wyeth (WYE), announced that four scientific abstracts regarding Lybrel (0.09 mg ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Contraception; First scientific data for Lybrel presented at ASRM... - Nov 14, 2005 2005 NOV 14 - (NewsRx.com) -- Wyeth Pharmaceuticals, a division of Wyeth (WYE), announced that four scientific abstracts regarding Lybrel (0.09 mg ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones Press Release: Data Show Low Incidence of Breakthrough Bleeding With ... - May 9, 2007 Data Show Low Incidence of Breakthrough Bleeding With ORTHO TRI-CYCLEN(R) LO In a Broad Range of Women. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Lybrel: levonorgestrel 90 mcg/ethinyl estradiol 20 mcg.(New formulatio... - Jul 1, 2007 This contraceptive is the first low-dose combination pill that is taken 365 days per year, thus leading to a cessation of bleeding. ... $4.95 - Formulary - ECNext Pill acts on acne - Sep 4, 2005 BY TEE SHIAO EEK. GOING on “the Pillâ€? used to be so risqué. From the 1960s right up to the '80s, the thought of women taking contraception into their own ... Malaysia Star Duramed withdraws NDA for Lo Seasonale EC oral contraceptive - Apr 7, 2006 The subsidiary of Barr Pharmaceuticals, Inc., Duramed Pharmaceuticals, Inc., has withdrawn its New Drug Application (NDA) for Lo Seasonale ... pharmabiz.com Pill power: Clinicians speak out on OC choices - Nov 1, 2005 The young woman sitting in front of you is in good health and says she would like to use a birth control pill. Which pill do you prescribe? ... Pay-Per-View - Contraceptive Technology Update - Factiva, from Dow Jones Barr and Wyeth in Patent Lawsuit against Watson Pharmaceuticals - Apr 18, 2008 Watson from commercializing its generic LYBREL(R) (levonorgestrel ethinyl estradiol tablets) prior to the expiration of US patent number 6500814. ... Lifescience-online STEPS - American Family Physician - Jan 15, 2008 Each tablet of Lybrel is composed of 90 mcg of levonorgestrel and 20 mcg of ethinyl estradiol. It is labeled for use as a continuous-cycle oral ... AAFP News Now Extended Cycle Birth Control - How Safe Is It? - Feb 18, 2007 Feb. 18 -- Some say extended cycle birth control pills are revolutionizing contraception for many women because it provides fewer periods, which means less ... go.com Press Release: Barr's Duramed Withdraws NDA for Lo SEASONALE(R) … - Apr 6, 2006 Barr's Duramed Withdraws NDA for Lo SEASONALE(R) Extended-Cycle Oral Contraceptive. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Barr Receives Approvable Letter for Duramed's SEASONIQUE(TM) … - Aug 28, 2005 Barr Pharmaceuticals, Inc confirmed that the US Food and Drug Administration (FDA) has issued an Approvable letter for Duramed Pharmaceuticals, ... i-newswire.com Press Release: Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing … - Feb 25, 2008 Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research FDA Approves Duramed's SEASONIQUE(TM) Extended-Cycle Oral … - May 25, 2006 WOODCLIFF LAKE, NJ, May 25 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that the US Food and Drug Administration (FDA) has approved ... Free with registration - PR Newswire - AccessMyLibrary.com Barr Confirms That Additional Clinical Data Is Not Required for... - Mar 17, 2006 WOODCLIFF LAKE, NJ, March 17 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today was informed by the US Food and Drug Administration (FDA) that ... RedOrbit Barr receives approvable letter for Duramed's Seasonique extended- … - Aug 18, 2005 Barr Pharmaceuticals Inc (Barr) confirmed that the US Food and Drug Administration (FDA) has issued an Approvable letter for Duramed Pharmaceuticals Inc's ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Product news from the 03/17/06 News Brief - Mar 17, 2006 Berlex, a US affiliate of Schering AG, Germany, said today that the FDA has approved Yaz (3 mg drospirenone/20 mcg ethinyl estradiol), a new monophasic oral ... Medical Marketing & Media - Medical Marketing and Media Barr Receives Approvable Letter for Duramed's SEASONIQUE(TM) … - Aug 22, 2005 Barr Pharmaceuticals, Inc confirmed that the US Food and Drug Administration (FDA) has issued an Approvable letter for Duramed Pharmaceuticals, ... Medical News Today - Medical News Today (press release) Watson Pharmaceuticals (WPI) Receives Final FDA Approval for Generic ... - Sep 7, 2006 Watson Pharmaceuticals, Inc. (NYSE: WPI) has received final approval from the United States (US) Food and Drug Administration on its Abbreviated New Drug ... StreetInsider.com - StreetInsider.com (subscription) Contraception; Approvable letter issued for Seasonique extended-cycle... - Sep 13, 2005 2005 SEP 13 - (NewsRx.com) -- Barr Pharmaceuticals, Inc., (BRL) confirmed that the US Food and Drug Administration (FDA) has issued an approvable letter for ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Barr Pharmaceuticals, Inc. SEASONIQUE NDA accepted for filing by US … - Jan 19, 2005 2005 JAN 19 - (NewsRx.com & NewsRx.net) -- Barr Pharmaceuticals, Inc., (BRL) announced that its subsidiary, Duramed Pharmaceuticals, Inc., has received ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Press Release: SEASONIQUE(R) Patent Issues. - PR Newswire | … - Jan 23, 2008 SEASONIQUE(R) Patent Issues. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Watson Pharmaceuticals Receives FDA Tentative Approval for Generic … - May 9, 2006 CORONA, Calif., May 9 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced that it has received ... RedOrbit Sexual and Reproductive Health; SEASONIQUE NDA accepted for filing … - Jan 23, 2005 2005 JAN 23 - (NewsRx.com & NewsRx.net) -- Barr Pharmaceuticals, Inc., (BRL) announced that its subsidiary, Duramed Pharmaceuticals, Inc., has received ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones Press Release: FDA Approves Duramed's LoSEASONIQUE(R) Oral … - Oct 27, 2008 FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research In acne therapy hormonal therapy plays role as adjunct. - Nov 1, 2006 Hormonal therapy may play an important role in the management of acne, but even in patients with indications for use of an anti-androgen agent, ... $4.95 - Dermatology Times - ECNext Continuous-Use Low-Dose Oral Contraceptive May Help Alleviate Cycle- … - Oct 18, 2005 By Amanda Strong. MONTREAL, QC -- October 18, 2005 -- Menstrual cycle-related symptoms can be improved with a continuous-use, low-dose, oral contraceptive ... DG News (WYE) SqueezeTrigger Price is $46.967. There is $379,813,892.00 That ... - Oct 9, 2007 BUYINS.NET / www.squeezetrigger.com is monitoring Wyeth (NYSE:WYE) in real time and just received an alert that is crossing above its primary SqueezeTrigger ... Free with registration - M2 Presswire - AccessMyLibrary.com First-Time Generic Approvals: Seasonale, Imodium Advanced, and … - Sep 22, 2006 Levonorgestrel/ethinyl estradiol is indicated for contraceptive use in women. The extended-cycle regimen consists of 84 active pills followed by 7 placebo ... Medscape Sexual and Reproductive Health; SEASONIQUE NDA accepted for filing … - Jan 17, 2005 2005 JAN 17 - (NewsRx.com & NewsRx.net) -- Barr Pharmaceuticals, Inc., (BRL) announced that its subsidiary, Duramed Pharmaceuticals, Inc., has received ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones Consolidation pace steady as big companies get bigger.(Special Report... - Sep 24, 2007 In order to compete with big brand-name drug companies, some generic manufacturers have consolidated to form juggernauts in the pharmaceutical industry. ... Free with registration - Drug Store News - AccessMyLibrary.com Press Release: Barr Receives Approvable Letter for Duramed's … - Aug 18, 2005 Barr Receives Approvable Letter for Duramed's SEASONIQUE(TM) Extended-Cycle Oral Contraceptive. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research New extended-use OC makes every pill count.(NEW DRUG) - Jul 10, 2006 Pharmacists can soon offer to women an extended-use oral contraceptive (OC) regimen that contains low-dose ethinyl estradiol tablets in place of placebo ... $4.95 - Drug Topics - ECNext Studies Examine Menopause Treatments, Oral Contraception To … - Jan 2, 2007 ..."Treating Symptoms of Menopause: a Study of the Effectiveness of Black Cohosh Alone and With Other Herbal Therapies or Soy," Annals of Internal Medicine ... Medical News Today - Medical News Today (press release) Wyeth Sues Sandoz to Block Generic Lybrel - Jun 10, 2008 Wyeth has brought a patent infringement suit to prevent approval of Sandoz's generic version of the oral contraceptive Lybrel. ... FDA news - FDA news (subscription) Generics makers keep product pipeline moving. - Sep 25, 2006 Generics makers keep product pipeline moving. NEW YORK--A number of generic drug companies have announced new product launches or marketing approvals. ... $20.00 - Chain Drug Review - Alacra Store Watson Pharmaceuticals; Officials at Watson Pharmaceuticals discuss … - Dec 19, 2006 Levonorgestrel ethinyl estradiol tablets USP is the generic equivalent to Duramed Pharmaceuticals' Seasonale tablets, which is indicated for prevention of ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Press Release: Watson Pharmaceuticals Receives FDA Tentative … - May 9, 2006 Watson Pharmaceuticals Receives FDA Tentative Approval for Generic Seasonale(R). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: FDA Approves Duramed's SEASONIQUE(TM) Extended- … - May 25, 2006 FDA Approves Duramed's SEASONIQUE(TM) Extended-Cycle Oral Contraceptive Company's Second Proprietary Extended-Cycle OC to be Available in July. from PR ... Pay-Per-View - PR Newswire - HighBeam Research Delaying your period through oral contraceptives - Oct 4, 2008 Not all doctors think it's a good idea to delay menstrual periods. Even those who support the option may not mention it to their patients. ... MayoClinic.com Poland's PiS slams Wyeth Lybrel launch.(Wyeth Pharmaceuticals)(Brief ... - Jun 11, 2007 Politicians from Law and Justice (PiS), the party that leads Poland's family values, right-wing coalition, have attacked plans by US drug major Wyeth to ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Shire and Barr Settle All Pending Litigation Concerning ADDERALL XR(R... - Aug 14, 2006 BASINGSTOKE, England and PHILADELPHIA, Aug. 14 /PRNewswire-FirstCall/ -- Shire plc announces that it has settled all pending litigation with Barr ... RedOrbit Article: GENERICS DRIVE GROWTH.(Business) - The Cincinnati Post ( … - Feb 8, 2006 GENERICS DRIVE GROWTH.(Business) ... find The Cincinnati Post (Cincinnati, OH) articles. WOODCLIFF LAKE, NJ -- Barr Pharmaceuticals Inc. said Tuesday that ... Pay-Per-View - Cincinnati Post - HighBeam Research (WYE) SqueezeTrigger Price is $46.959. There is $380,216,152.00 That ... - Oct 23, 2007 BUYINS.NET / www.squeezetrigger.com is monitoring Wyeth (NYSE:WYE) in real time and just received an alert that is crossing above its primary SqueezeTrigger ... Free with registration - M2 Presswire - AccessMyLibrary.com Pill to end misery of PMS - Oct 24, 2006 By ROGER DOBSON. Migraine, mood swings, irritability, bloating ? these are just some of the debilitating pre-menstrual symptoms many women experience every ... Daily Mail FDA Approval Decisions Report November-January 2009 - Nov 1, 2008 1. 2. FDA Approval Decisions Report. November-January 2009. Overview. For investors in pharmaceutical and biotech companies, rigorous monitoring of drug ... $125.00 - Revere Reports - Revere MIDAS Research Initiates Research Coverage on Estracure, Inc. |... - Apr 29, 2005 MIDAS Research Initiates Research Coverage on Estracure, Inc. ... find PR Newswire Europe articles. TORONTO, April 29 /PRNewswire/ -- DURAVEST, INC. Pay-Per-View - PR Newswire Europe - HighBeam Research The Market for Anxiety Disorders is Expected to Decrease to $2.6... - Apr 13, 2006 Research and Markets (http://www.researchandmarkets.com/reports/c35607) has announced the addition of Anxiety Disorders - A Decade of Declining Revenues to ... Genetic Engineering News - Genetic Engineering News (press release) Pipeline Insight: Anxiety Disorders - A Decade of Declining Revenues... - Mar 29, 2006 Table 10: Marketed anxiety drugs approved for specific anxiety disorders, in the US, EU and Japan. Figure 6: Drug classes in development for the treatment ... MarketResearch.com (WYE) SqueezeTrigger Price is $46.961. There is $288,434,300.00 That ... - Nov 27, 2007 M2 PRESSWIRE-27 November 2007-BUYINS.NET: (WYE) SqueezeTrigger Price is $46.961. There is $288434300.00 That Short Sellers Still Need To Cover(C)1994-2007 ... $4.95 - M2 Presswire - ECNext (WYE) SqueezeTrigger Price is $46.961. There is $288,557,038.00 That ... - Nov 14, 2007 M2 PRESSWIRE-14 November 2007-BUYINS.NET: (WYE) SqueezeTrigger Price is $46.961. There is $288557038.00 That Short Sellers Still Need To Cover(C)1994-2007 ... $4.95 - M2 Presswire - ECNext Press Release: Barr Names G. Frederick Wilkinson President and COO of... - Jan 10, 2006 Barr Names G. Frederick Wilkinson President and COO of Duramed Pharmaceuticals, Inc. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Appro letter for Barr/ Duramed's Seasonique.(Barr Pharmaceuticals)( … - Aug 29, 2005 The US Food and Drug Administration has issued Barr Pharmaceuticals with an approvable letter for Duramed Pharmaceuticals' New Drug Application for ... $4.95 - Pharma Marketletter - ECNext The market for anxiety disorders is expected to decrease to $2.6... - Apr 12, 2006 M2 PRESSWIRE-12 April 2006-Research and Markets: The market for anxiety disorders is expected to decrease to $2.6 billion by 2015. ... $4.95 - M2 Presswire - ECNext Factiva Search - Feb 1, 2005 Factiva Search 2.0. BETA. Factiva iWorksâ„¢ offers Factiva's exclusive collection of world-class information indexed and optimized for business use. ... Pay-Per-View - Med Ad News - Factiva, from Dow Jones Market Analysis; Anxiety disorders drug market likely to decrease... - May 18, 2006 2006 MAY 18 - (NewsRx.com) -- The global anxiety disorders market is set to decline from $4.5 billion in 2006 to $2.6 billion by 2015 primarily due to the ... Pay-Per-View - Biotech Business Week - Factiva, from Dow Jones Business Update; Duramed and Shire sign deals for Adderall - Sep 12, 2006 2006 SEP 12 - (NewsRx.com) -- Barr Pharmaceuticals, Inc. (BRL) announced that its subsidiary, Duramed Pharmaceuticals, Inc., and Shire plc (SHPGY, SHQ, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Press Release: Shire and Barr Settle All Pending Litigation Concerning... - Aug 15, 2006 Shire and Barr Settle All Pending Litigation Concerning ADDERALL XR(R) and enter into Development and License Agreement. from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research Wyeth's New Drug Application for New Oral Contraceptive With … - Jul 27, 2005 MADISON, NJ, July 27 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , announced today that the US Food and Drug Administration (FDA) ... $4.95 - PR Newswire - ECNext Press Release: Barr Launches a Generic Version of its SEASONALE(R) … - Sep 7, 2006 Barr Launches a Generic Version of its SEASONALE(R) Extended-Cycle Oral Contraceptive. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Shire and Barr Settle All Pending Litigation Concerning... - Aug 15, 2006 Shire and Barr Settle All Pending Litigation Concerning ADDERALL XR(R) and enter into Development and License Agreement. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research (WYE) SqueezeTrigger Price is $46.961. There is $288,679,776.00 That ... - Nov 26, 2007 M2 PRESSWIRE-26 November 2007-BUYINS.NET: (WYE) SqueezeTrigger Price is $46.961. There is $288679776.00 That Short Sellers Still Need To Cover(C)1994-2007 ... $4.95 - M2 Presswire - ECNext Wyeth Reports Earnings Results for the 2005 Third Quarter and First... - Oct 21, 2005 The Company is awaiting FDA action regarding the NDA submitted in May 2005 for LYBREL(TM) (levonorgestrel/ethinyl estradiol) a new oral contraceptive with a ... $4.95 - PR Newswire - ECNext Wyeth Reports Earnings Results for the 2005 Fourth Quarter and Full … - Jan 31, 2006 MADISON, NJ, Jan. 31 /PRNewswire-FirstCall/ -- Wyeth today reported results for the 2005 fourth quarter and full year. Worldwide net revenue increased 2% to ... $4.95 - PR Newswire - ECNext Press Release: Watson Confirms Patent Litigation With Barr Related to... - Dec 14, 2007 Watson Confirms Patent Litigation With Barr Related to Seasonale(R). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Wyeth Reports Earnings Results for the 2006 First Quarter. - Apr 21, 2006 MADISON, NJ, April 21 /PRNewswire-FirstCall/ -- Wyeth today reported results for the 2006 first quarter ending March 31, 2006. ... $4.95 - PR Newswire - ECNext Barr and Shire settle Adderall XR dispute: generic entry in 2009, no... - Aug 21, 2006 UK drugmaker Shire has settled all pending litigation regarding US firm Barr Laboratories' attempt to market generic versions of Adderall XR ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Keep your eye on the target: set your target IOP early (and reassess ... - Oct 15, 2006 A 38-year-old white female presented as a new patient seeking a second opinion about her recently diagnosed glaucoma. Her last doctor prescribed Travatan ... Free with registration - Review of Optometry - AccessMyLibrary.com Clinical news: Continuous-use contraceptive pill `safe'.(Brief... - Dec 30, 2006 Continuous use of a combined levonorgestrel/ ethinyl estradiol contraceptive is safe and eliminates periods in more than half of women, a phase 3 trial has ... Free with registration - Chemist & Druggist - AccessMyLibrary.com MORNING AFTER PILL Pictures from August 22, 2007 | HighBeam … - Aug 22, 2007 Find pictures of MORNING AFTER PILL from August 22, 2007 in the AP Images collection at HighBeam Research. Pay-Per-View - AP Images - HighBeam Research Shire plc: On Time Execution of Operating Plan Delivers Strong 2006 … - Feb 20, 2007 BASINGSTOKE, England, February 20 /PRNewswire-FirstCall/ -- Shire plc announces results for the twelve months to December 31, 2006 - a year in which ... $4.95 - PR Newswire - ECNext (WYE) SqueezeTrigger Price is $46.931. There is $537,544,635.00 That ... - Sep 5, 2007 M2 PRESSWIRE-5 September 2007-BUYINS.NET: (WYE) SqueezeTrigger Price is $46.931. There is $537544635.00 That Short Sellers Still Need To Cover(C)1994-2007 ... $4.95 - M2 Presswire - ECNext Press Release: SHIRE PLC - Final Results. - PR Newswire UK Disclose |... - Feb 20, 2007 SHIRE PLC - Final Results. from PR Newswire UK Disclose. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire UK Disclose - HighBeam Research (WYE) SqueezeTrigger Price is $46.970. There is $378,285,304.00 That ... - Oct 4, 2007 M2 PRESSWIRE-4 October 2007-BUYINS.NET: (WYE) SqueezeTrigger Price is $46.970. There is $378285304.00 That Short Sellers Still Need To Cover(C)1994-2007 M2 ... $4.95 - M2 Presswire - ECNext Generic consolidations create global powerhouses. - Aug 13, 2007 Generic consolidations create global powerhouses. The name of the game in the generic drug industry is consolidation. "It leverages your strengths: Your ... $20.00 - Drug Store News - Alacra Store Wyeth unveils seven late-stage drugs for 11 indications at its annual... - Oct 16, 2006 Wyeth unveils seven late-stage drugs for 11 indications at its annual R&D presentation. US drug major Wyeth showcased a robust pipeline of late-stage drug ... $9.94 - Pharma Marketletter - Alacra Store US FDA accepts NDA on Wyeth's birth-control pill. - Aug 8, 2005 US drug major Wyeth says that its New Drug Application for a new combination oral contraceptive, containing levonorgestrel/ethinyl estradiol with a unique ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Misleading ads.(POLICY & PRACTICE) | Article from OB GYN News | … - Feb 1, 2005 Misleading ads.(POLICY & PRACTICE) ... find OB GYN News articles. The Food and Drug Administration recently warned Barr Research that one of its ... Pay-Per-View - OB GYN News - HighBeam Research Wyeth's revenues hit $5.2B for 1st-half 2006. - Jul 31, 2006 Wyeth's revenues hit $5.2B for 1st-half 2006. US drug major Wyeth says that it achieved worldwide net revenue of $10.0 billion in the first half of 2006, ... $9.94 - Pharma Marketletter - Alacra Store Article: OTC Morning-After Pill Decision Delayed - AP Online |... - Jan 24, 2005 OTC Morning-After Pill Decision Delayed ... find AP Online articles. AP Online 01-24-2005 Dateline: WASHINGTON The Food and Drug Admin... Pay-Per-View - AP Online - HighBeam Research After reading Contraceptive Technology Update, the participant will... - Jan 1, 2006 ...*Identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive services. ... Pay-Per-View - Contraceptive Technology Update - Factiva, from Dow Jones Factiva Search - Jun 7, 2006 Factiva Search 2.0. BETA. Factiva iWorksâ„¢ offers Factiva's exclusive collection of world-class information indexed and optimized for business use. ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones Factiva Search - Jun 5, 2006 Factiva Search 2.0. BETA. Factiva iWorksâ„¢ offers Factiva's exclusive collection of world-class information indexed and optimized for business use. ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Article: NO DECISION ON MORNING-AFTER PILL.(FRONT) - The Capital … - Jan 22, 2005 NO DECISION ON MORNING-AFTER PILL.(FRONT) ... find The Capital Times (Madison, WI) articles. The government has delayed a decision on whether to allow women ... Pay-Per-View - Capital Times - HighBeam Research US FDA accepts NDA on Wyeth's birth-control pill.(Food and Drug … - Aug 8, 2005 US drug major Wyeth says that its New Drug Application for a new combination oral contraceptive, containing levonorgestrel/ethinyl estradiol with a unique ... $4.95 - Pharma Marketletter - ECNext Article: FDA Eases Limits on Plan B Sales - AP Online | HighBeam … - Aug 24, 2006 FDA Eases Limits on Plan B Sales ... find AP Online articles. WASHINGTON - Women may buy the morning-after pill without a prescription - but only with proof ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Press Release: Wyeth's New Drug Application for New Oral Contraceptive... - Jul 27, 2005 Wyeth's New Drug Application for New Oral Contraceptive With Uninterrupted Dosing Regimen Accepted for Filing at FDA. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Watson Pharmaceuticals Inc. - Sep 25, 2006 Watson Pharmaceuticals Inc. CORONA, Calif. -- With more than 20 years in the generics business behind it, Watson Pharmaceuticals Inc. has established itself ... $9.94 - Chain Drug Review - Alacra Store New Jersey Administrative Code - 8:71-1.1 Precedence of lists - Aug 16, 2005 8:71-1.1 Precedence of lists (a) A drug product that appears on one of the lists provided at either (b) or (c) below shall be an interchangeable drug ... Pay-Per-View - New Jersey Administrative Code - Loislaw Un nou anticonceptional recomandat de medici SEASONIQUE - Jun 1, 2006 Noul contraceptiv oral produs de firma Barr Pharmaceuticals, Inc (Duramed Pharmaceuticals, Inc.) a fost aprobat de FDA si va fi disponibil in farmacii din ... Ziare.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
